Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $30,240 | 8 | 49.6% |
| Travel and Lodging | $22,724 | 12 | 37.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,800 | 2 | 6.2% |
| Honoraria | $3,360 | 2 | 5.5% |
| Food and Beverage | $783.32 | 13 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ROCHE MOLECULAR SYSTEMS, INC. | $27,636 | 15 | $0 (2019) |
| Visby Medical, Inc. | $15,000 | 4 | $0 (2024) |
| Gilead Sciences Inc | $8,717 | 8 | $0 (2017) |
| Roche Diagnostics Corporation | $3,440 | 4 | $0 (2017) |
| La Jolla Pharmaceutical Company | $2,042 | 3 | $0 (2024) |
| Gen-Probe Sales & Service, Inc. | $1,752 | 1 | $0 (2018) |
| Life Technologies Corporation | $1,400 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $920.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,042 | 7 | Visby Medical, Inc. ($15,000) |
| 2021 | $1,400 | 1 | Life Technologies Corporation ($1,400) |
| 2019 | $27,566 | 14 | ROCHE MOLECULAR SYSTEMS, INC. ($27,566) |
| 2018 | $2,672 | 2 | Gen-Probe Sales & Service, Inc. ($1,752) |
| 2017 | $12,228 | 13 | Gilead Sciences Inc ($8,717) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Visby Medical, Inc. | Visby Medical Sexual Health Click Test (Device), Visby Medical Respiratory Health Test | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Sexual Health Test | ||||||
| 11/20/2024 | La Jolla Pharmaceutical Company | — | Honoraria | Cash or cash equivalent | $1,608.00 | General |
| 11/20/2024 | La Jolla Pharmaceutical Company | — | Travel and Lodging | In-kind items and services | $272.70 | General |
| 11/20/2024 | La Jolla Pharmaceutical Company | — | Food and Beverage | In-kind items and services | $161.20 | General |
| 09/13/2024 | Visby Medical, Inc. | Visby Medical Sexual Health Click Test (Device), Visby Medical Respiratory Health Test | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Sexual Health Test | ||||||
| 06/20/2024 | Visby Medical, Inc. | Visby Medical Sexual Health Click Test (Device), Visby Medical Respiratory Health Test | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Sexual Health Test | ||||||
| 04/05/2024 | Visby Medical, Inc. | Visby Medical Sexual Health Click Test (Device), Visby Medical Respiratory Health Test | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Sexual Health Test | ||||||
| 10/06/2021 | Life Technologies Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| 11/05/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Molecular Diagnostics | ||||||
| 11/05/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $332.00 | General |
| Category: Molecular Diagnostics | ||||||
| 11/05/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $32.39 | General |
| Category: Molecular Diagnostics | ||||||
| 09/30/2019 | ROCHE MOLECULAR SYSTEMS, INC. | COBAS INSTRUMENTS & REAGENTS (Device) | Food and Beverage | In-kind items and services | $130.38 | General |
| Category: Molecular Diagnostics | ||||||
| 07/15/2019 | ROCHE MOLECULAR SYSTEMS, INC. | COBAS INSTRUMENTS & REAGENTS (Device) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Molecular Diagnostics | ||||||
| 06/11/2019 | ROCHE MOLECULAR SYSTEMS, INC. | COBAS INSTRUMENTS & REAGENTS (Device) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Molecular Diagnostics | ||||||
| 06/11/2019 | ROCHE MOLECULAR SYSTEMS, INC. | COBAS INSTRUMENTS & REAGENTS (Device) | Travel and Lodging | In-kind items and services | $1,277.40 | General |
| Category: Molecular Diagnostics | ||||||
| 05/14/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $5,504.93 | General |
| Category: Molecular Diagnostics | ||||||
| 05/13/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Food and Beverage | In-kind items and services | $153.49 | General |
| Category: Molecular Diagnostics | ||||||
| 05/13/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Molecular Diagnostics | ||||||
| 05/12/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Molecular Diagnostics | ||||||
| 05/08/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $9,341.13 | General |
| Category: Molecular Diagnostics | ||||||
| 05/08/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $3,628.10 | General |
| Category: Molecular Diagnostics | ||||||
| 04/09/2019 | ROCHE MOLECULAR SYSTEMS, INC. | MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $208.10 | General |
| Category: Molecular Diagnostics | ||||||
| 10/25/2018 | Gen-Probe Sales & Service, Inc. | — | Honoraria | Cash or cash equivalent | $1,752.00 | General |
| 04/17/2018 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $920.00 | General |
| 12/21/2017 | Roche Diagnostics Corporation | MD cobas Instruments and Reagents (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Molecular Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 49 | 108 | $28,749 | $8,316 |
| 2022 | 4 | 61 | 111 | $30,222 | $8,369 |
| 2021 | 4 | 80 | 122 | $33,150 | $9,638 |
| 2020 | 1 | 12 | 27 | $5,670 | $1,536 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 35 | $10,395 | $3,124 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 49 | $10,290 | $2,907 | 28.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $5,940 | $1,561 | 26.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,124 | $722.76 | 34.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 36 | $10,692 | $2,775 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 45 | $9,450 | $2,472 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $7,425 | $2,296 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 15 | $2,655 | $825.45 | 31.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 20 | $9,900 | $3,139 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 52 | $10,920 | $2,957 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 29 | $8,613 | $2,348 | 27.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 21 | 21 | $3,717 | $1,195 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 27 | $5,670 | $1,536 | 27.1% |
About Edward Hook
Edward Hook is a Infectious Disease healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043247265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Hook has received a total of $60,907 in payments from pharmaceutical and medical device companies, with $17,042 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($30,240).
As a Medicare-enrolled provider, Hook has provided services to 202 Medicare beneficiaries, totaling 368 services with total Medicare billing of $27,859. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Birmingham, AL
- Active Since 06/26/2006
- Last Updated 06/01/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1043247265
Products in Payments
- MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT (Device) $21,713
- Visby Medical Sexual Health Click Test (Device) $15,000
- COBAS INSTRUMENTS & REAGENTS (Device) $5,923
- MD cobas Instruments and Reagents (Device) $2,850
- MD Research and Development (Device) $589.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Birmingham
Sonya Heath
Infectious Disease — Payments: $103,197
John Baddley, Md, MD
Infectious Disease — Payments: $101,314
Christina Muzny
Infectious Disease — Payments: $87,717
Edgar Overton
Infectious Disease — Payments: $78,314
Peter Pappas
Infectious Disease — Payments: $73,326
William Geisler, Md, MD
Infectious Disease — Payments: $66,779